These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Rituximab versus cyclophosphamide for the treatment of connective tissue disease-associated interstitial lung disease (RECITAL): study protocol for a randomised controlled trial. Saunders P; Tsipouri V; Keir GJ; Ashby D; Flather MD; Parfrey H; Babalis D; Renzoni EA; Denton CP; Wells AU; Maher TM Trials; 2017 Jun; 18(1):275. PubMed ID: 28619061 [TBL] [Abstract][Full Text] [Related]
4. Learnings from clinical trials in patients with connective tissue disease-associated interstitial lung disease. Higuero Sevilla JP; Memon A; Hinchcliff M Arthritis Res Ther; 2023 Jul; 25(1):118. PubMed ID: 37422652 [TBL] [Abstract][Full Text] [Related]
5. Review series: Aspects of interstitial lung disease: connective tissue disease-associated interstitial lung disease: how does it differ from IPF? How should the clinical approach differ? de Lauretis A; Veeraraghavan S; Renzoni E Chron Respir Dis; 2011; 8(1):53-82. PubMed ID: 21339375 [TBL] [Abstract][Full Text] [Related]
7. Treatment of connective tissue disease-associated interstitial lung disease: the pulmonologist's point of view. Koo SM; Uh ST Korean J Intern Med; 2017 Jul; 32(4):600-610. PubMed ID: 28704913 [TBL] [Abstract][Full Text] [Related]
8. Interstitial lung disease in connective tissue disorders. Fischer A; du Bois R Lancet; 2012 Aug; 380(9842):689-98. PubMed ID: 22901890 [TBL] [Abstract][Full Text] [Related]
9. Mycophenolate mofetil improves lung function in connective tissue disease-associated interstitial lung disease. Fischer A; Brown KK; Du Bois RM; Frankel SK; Cosgrove GP; Fernandez-Perez ER; Huie TJ; Krishnamoorthy M; Meehan RT; Olson AL; Solomon JJ; Swigris JJ J Rheumatol; 2013 May; 40(5):640-6. PubMed ID: 23457378 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of antifibrotic agents in the treatment of CTD-ILD and RA-ILD: A systematic review and meta-analysis. Yang M; Wu Y; Liu X; Zhao C; Li T; Li T; Zhang X; Jiang H; Mao B; Liu W Respir Med; 2023 Sep; 216():107329. PubMed ID: 37315742 [TBL] [Abstract][Full Text] [Related]
11. Management of interstitial lung disease associated with connective tissue disease. Mathai SC; Danoff SK BMJ; 2016 Feb; 352():h6819. PubMed ID: 26912511 [TBL] [Abstract][Full Text] [Related]
12. Characteristics and risk factors of interstitial pneumonia with autoimmune features. Vahidy S; Agyeman J; Zheng B; Donohoe K; Hambly N; Johannson KA; Assayag D; Fisher JH; Manganas H; Marcoux V; Khalil N; Kolb M; Ryerson CJ; ; Wong AW; Lok S; Morisset J; Fell CD; Shapera S; Gershon AS; Cox G; Halayko AJ; Sadatsafavi M; Wilcox PG; To T Respir Med; 2024 Jan; 221():107500. PubMed ID: 38142756 [TBL] [Abstract][Full Text] [Related]
13. Connective tissue disease--associated interstitial lung disease: an underreported cause of interstitial lung disease in Sub-Saharan Africa. Olaosebikan H; Adeyeye O; Akintayo R; Akpabio A; Adenitan A; Adelowo O; Ojo O; Abimbola FO Clin Rheumatol; 2021 Sep; 40(9):3455-3460. PubMed ID: 32803569 [TBL] [Abstract][Full Text] [Related]
15. Targeting CD20 in the treatment of interstitial lung diseases related to connective tissue diseases: A systematic review. Bellan M; Patrucco F; Barone-Adesi F; Gavelli F; Castello LM; Nerviani A; Andreoli L; Cavagna L; Pirisi M; Sainaghi PP Autoimmun Rev; 2020 Feb; 19(2):102453. PubMed ID: 31838163 [TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of rituximab in connective tissue disease-associated interstitial lung disease: A systematic review and meta-analysis. Xing NS; Fan GZ; Yan F; Liu YP; Zhang R Int Immunopharmacol; 2021 Jun; 95():107524. PubMed ID: 33721757 [TBL] [Abstract][Full Text] [Related]
17. Treatment of interstitial lung diseases associated with connective tissue diseases. Kobayashi A; Okamoto H Expert Rev Clin Pharmacol; 2012 Mar; 5(2):219-27. PubMed ID: 22390563 [TBL] [Abstract][Full Text] [Related]
18. [Interstitial lung disease in rheumatic diseases - new therapeutic approaches]. Jakubczyc A; Neurohr C Dtsch Med Wochenschr; 2020 Apr; 145(7):470-473. PubMed ID: 32236928 [TBL] [Abstract][Full Text] [Related]
19. Current approach to connective tissue disease-associated interstitial lung disease. Solomon JJ; Chartrand S; Fischer A Curr Opin Pulm Med; 2014 Sep; 20(5):449-56. PubMed ID: 25022317 [TBL] [Abstract][Full Text] [Related]
20. Interstitial lung disease in the connective tissue diseases. Antin-Ozerkis D; Rubinowitz A; Evans J; Homer RJ; Matthay RA Clin Chest Med; 2012 Mar; 33(1):123-49. PubMed ID: 22365251 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]